Pier Paolo Piccaluga is an Associate Professor of Pathology at the Department of Medical and Surgical Sciences at the Bologna University School of Medicine. He is also a co-founder and Executive Physician at the Biobank of Research, IRCCS S. Orsola-Malpighi Hospital in Italy. He has led the Molecular Hematopathology Laboratory for many years. In 2018, he was appointed to teach at Queen Mary University of London (UK) and Jomo Kenyatta University of Agriculture and Technology in Nairobi (Kenya), and since 2023, at the University of Nairobi and the University of Botswana. He is the author of several international publications indexed in the Current Contents (including Nature Medicine, Journal of Clinical Investigation, Journal of Experimental Medicine, Journal of Clinical Oncology, Blood, Lancet Oncology, and Lancet Infectious Diseases, with a total impact factor >1,000, a mean impact factor >6, and an H-index of 62 (ranked among the VIA-Academy Top Italian Scientists). He is the author of several presentations at national and international conferences. Dr. Piccaluga has participated in several clinical trials as a coordinator or sub-investigator and has won multiple awards for his contributions to study and research. He has served as a Principal Investigator (PI) in various research projects funded by nationally and internationally recognized organizations. He is the Editor-in-Chief of the World Journal of Hematology, Digital Medicine and Healthcare Technology, Advances in Precision Medicine, and the Journal of Cancer Biomoleculars and Therapeutics.

Prof. Farid Menaa is an inter- and multi-disciplinary experienced professional with worldwide reputation. During his ongoing career he has mainly contributed to the identification and the characterization of genetic biomarkers of diseases, as well as to the development of pharmaceutical theragnostic solutions. He has a solid background and experience in academic, governmental and industrial environments, He is a member of several prestigious organizations and sits on numerous editorial boards of reputed journals. He has authored more than 200 articles, reviewed more than 1000 articles for the medical and scientific communities, and has participated to over 600 scientific international events where he sometimes acts as chairman and/or co-organizer. Dr. Menaa is a co-pioneer of CFS, a spectroscopy-based technology with unique features and large applicability in sciences, technologies, and innovations. Dr. Menaa is currently an international health expert and consultant specialist. He is the founder and CEO of MENAA group (Medicine Engineering Nanotechnology in Asia and Arabia) promoting advising and development in R&D&I in the Asian & Arabic regions of the globe.

From 1980 through 1985 has been working as Res Associate, at the Inst of Medicical Enzymolo-gy, USSR Academy of Medical Sciences. In 1989-1993, was trained at the NEI, NIH, Bethesda, MD, USA, and Wills Eye Hospital, Philadelphia, PA, USA, as well as at some of the British universities on the invitation of the Royal Society for Immunology. From 1994 through 2006, was a Director of the Division for Clinical Immunology & Immunobiotechnology, Vladimiskii Moscow Clinical Research Institute (MONIKI). From 2006 through 2014, was The First Vice-President responsible for Personalized and Precision Medicine of The University of World Politics and Law, Moscow, Russia. From 2003 through 2021, was a Professor of the Dept for Clinical Human Pathology of Sechenov University, Moscow, Russia. From 2014 through 2021, was a Professor and Chair of the Dept (since 2016 The Director of the Center) for Personalized & Pre-cision Medicine of Sechenov University, Moscow, Russia. From 2021 through Jan 2023, is a Professor, Chair of the Dept for Personalized Medicine, Precision Nutriolo-gy & Biodesign, and Vice-Director for Research, International Collaboration & De-velopment of the Institute for Biotechology & Global Health of the RosBioTech Na-tional University, Russia. From 2007 through 2024, is a Professor of the Dept for Clinical Allergology & Immunology of the Russian University of Medicine, Moscow, Russia. At present, Dr Sergey Suchkov is: Professor in Medicine & Immunology and R&D Director of the National Center for Human Photosynthesis, Aguascalientes, México; Senior Scientific Advisor, InMedStar, Russia; Member, New York Academy of Sciences, USA; Member, The Russian Academy of Natural Sciences (RANS), Russia; Member, EPMA (European Association for Predictive, Preventive and Personal-ized Medicine), Brussels, EU; Member, ISPM (International Society for Personalized Medicine), Japan; Member, PMC (Personalized Medicine Coalition), Washington, USA; Member, AMEE (Association for Medical Education in Europe), Dundee, Scot-land; Member, ACS (American Chemical Society), Washington, DC, USA; Member, AHA (American Heart Association), Dallas, TX, USA; Member, ARVO (The Association in Research in Vision & Ophthalmology), Rockville, MD, USA; Member, ISER (International Society for Eye Research), Anchorage, AK USA; Secretary General, United Cultural Convention (UCC), Cambridge, UK.

Professor Habib Zaidi is Chief physicist and head of the PET Instrumentation & Neuroimaging Laboratory at Geneva University Hospital and faculty member at the medical school of Geneva University. He is also a Professor of Medical Physics at the University of Groningen (Netherlands), Adjunct Professor of Medical Physics and Molecular Imaging at the University of Southern Denmark, Adjunct Professor of Medical Physics at Shahid Beheshti University and visiting Professor at Tehran University of Medical Sciences. He was guest editor for 12 special issues of peer-reviewed journals, and serves as founding Editor-in-Chief (scientific) of the British Journal of Radiology (BJR)|Open, Deputy Editor for Medical Physics, and member of the editorial board of the International Journal of Imaging Systems and Technology, International Journal of Biomedical Imaging, Clinical and Translational Imaging, American Journal of Nuclear Medicine and Molecular Imaging, Brain Imaging Methods (Frontiers in Neuroscience & Neurology), Cancer Translational Medicine and the IAEA AMPLE Platform in Medical Physics. He has been elevated to the grade of fellow of the IEEE, AIMBE and the AAPM and was elected liaison representative of the International Organization for Medical Physics (IOMP) to the World Health Organization (WHO) and member of the International Medical Physics Certification Board (IMPCB) and the Imaging Physics Committee of the American Association of Physicists in Medicine (AAPM) in addition to being affiliated to several International medical physics and nuclear medicine organisations. Prof. Zaidi has been an invited speaker of over 160 keynote lectures and talks at an international level, has authored over 600 publications, including 310 peer-reviewed journal articles in prominent journals, 280 conference proceedings and 38 book chapters and is the editor of four textbooks.

Dr. Thomas Böldicke received his PhD 1982 at the Max-Planck-Institut of Molecular Genetics, Berlin. He started his carrier as post doc at the German Research Centre for Biotechnology (GBF, Braunschweig, Germany) in the Department of Genetics and Cell Biology by John Collins. Now he is senior scientist at the Helmholtz Centre for Infection Research (HZI, former GBF) and project leader intrabodies. He developed recombinant antibodies against tumor antigens, particularly against tumour angiogenesis, rhabdyomyosarcoma and recently against TLR2 and TLR9 in pancreatic cancer. He edited two books: "Protein Targeting Compounds" with Springer (2016) and "Antibody Engineering" with IntechOpen (2017). He has published dozends papers on many international journals. Over 10 years he gave lectures at the Technical University in Braunschweig about immunology, cancer development and immunotherapies. He is in the editorial board of the journal Antibodies as academic editor, Frontiers in Immunology and Frontiers in Oncology.

Prof. Michele Mishto is Professor in Immunobiology at King's College London and Senior Group leader at the Francis Crick Institute in London (UK). PhD in Medical Biotechnology at University of Bologna (ITA) and a long post-doc and project leader experience at the Institute of Biochemistry at Universitätsmedizin Charite' Berlin (GER). He worked as research associate and project PI at the Institute for Biochemistry at Charité – Universitätsmedizin Berlin from 2005 to 2017.  And he is currently consultant for GSK. Michele Mishto's group has expertise in the function and biochemical activity of proteasomes, in conventional and unconventional antigen processing and presentation, as well as other immunobiology area. He develops multi-disciplinary projects that combine silico, in vitro, in cellula and in vivo strategies. He has published hundreds of articles on many international academic journals and conferences. His Google Scholar h-index is 37, and he has more than 3000 Citations.

Dr. Nan Zhang graduated from Harbin Institute of Technology with the master's degree, and he graduated from University College Dublin with the doctor's Degree. Dr. Nan Zhang has been the Postdoctoral Researcher of University College Dublin from 2013-2026. Since 2024, he is the Associate Professor of University College Dublin. He is the Member of American Chemical Society, Board member of The Microfluidic Association, Member of International Academy of Engineering and Technology, Professional Member of Society of Plastic Engineers, and Member of International Society of Nanomanufacturing (ISNM). He has been participated in many international academic conferences, like Chairman of 8th International Conference on Polymer Replication on Nanoscale and Chairman of the 6th International Conference on Polymer Replciation on Nanoscale. And he has been served as journal reviewer of Journal of Manufacturing and Materials Processing, Journal of Alloys and Compounds, Materials Research Express, Materials, Applied Sciences, Nanotechnology and Precision Engineering, Surface Topography: Metrology and Properties, Smart Materials and Structures, International Journal of Nanomanufacturing, Journal of Applied Polymer Science, Journal of Micromechanics and Microengineering, and Micromachines.

Joanna Bojarska has completed his PhD from Technical University, Poland. She has been working at the Institute of General and Ecological Chemistry at the same University. Now, she is the Associate Professor of Lodz University of Technology, Poland. She has published more than 40 papers in reputed journals, e-books and 100 international conference communications (on all world continents). She is a member of The European Peptide Society. She is awarded by verified certificate of Harvard University (Biochemistry upper-level course), Awards of the Dean of Faculty of Chemistry and the Rector of the Lodz University of Technology for outstanding achievements in science, teaching and popularization of crystallographic science. Joanna works at a university in Poland. She is a member of the Royal Society of Chemistry and the European Peptide Society. She earned a verified certificate from Harvard University and served as Guest Editor of the special issue in many internation academic journals.

Rahele Kafieh is an Assistant Professor in Bioengineering at Durham University and serves as an EPSRC Women in Engineering Ambassador. With a career spanning over 13 years in health-related projects and AI-driven medical data analysis, her contributions to the field are evidenced by over 120 research articles she has authored. Rahele has many projects, including grants such as the EPSRC IAA, UKRI MRC Ageing Research Development Award, Switzerland research seed money, Einstein Forum grant, National Institute for Medical Research Development grant, and TÜBİTAK grant. She has earned the Article of the Year Award from the Computational and Mathematical Methods in Medicine journal and honored with the Best Paper Award in the COVID domain by the Ministry of Health in Iran. Rahele is currently leading the EPSRC IAA project titled "Enhancing Healthcare with AI-Based Home Monitoring for Retinal Diseases," conducted in collaboration with Siloton Limited. One of her flagship projects, funded by the UKRI MRC award, is titled "OCTage: monitoring the ageing brain via Optical Coherence Tomography of the eyes" (MR/Y010825/1). She is a member of BioMedEng Association and Institute of Physics & Engineering in Medicine (IPEM). She was a Research Associate, at the Institute of Biosciences, at Newcastle University, Newcastle upon Tyne, United Kingdom from 2021 to 2022. And she was a guest researcher at Neurocure Clinical Research Center, Charite University, Berlin, Germany in 2018 and 2019.